Dr. Talati is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
AbbVie Headquarters
1 N Waukegan Rd
Lake Bluff, IL 60044- Is this information wrong?
Education & Training
University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2018
University at BuffaloResidency, Internal Medicine, 2012 - 2015
American University of Antigua College of MedicineClass of 2011
Certifications & Licensure
FL State Medical License 2015 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Clinical Trials
- Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia Start of enrollment: 2019 Apr 18
- Quality of Life Model for Older Patients With AML Start of enrollment: 2020 Jul 08
- CD8 Depleted, Non-engrafting, HLA Mismatched Unrelated Infusion With MDS and Secondary AML Start of enrollment: 2021 Jan 14
- Join now to see all
Publications & Presentations
PubMed
- Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AML.Onyee Chan, Najla Al Ali, Hammad Tashkandi, Austin Ellis, Somedeb Ball, Justin Grenet, Caroline Hana, Yehuda Deutsch, Ling Zhang, Mohammad Hussaini, Jinming Song, Seon...> ;Blood Advances. 2024 Mar 12
- Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia.Amanda Przespolewski, Aaron D Goldberg, Chetasi Talati, Salman Fazal, Pankit Vachhani, Srinivasa R Sanikommu, Swapna Thota, Julian Waksal, Brian Ball, Christopher Famu...> ;Blood. 2023 Mar 23
- Molecular characteristics and outcomes in Hispanic and non-Hispanic patients with acute myeloid leukemia.Terrence Bradley, Deukwoo Kwon, Jorge Monge, Mikkael Sekeres, Namrata Chandhok, Amber Thomassen, Ronan Swords, Eric Padron, Jeff Lancet, Chetasi Talati, Justin Watts> ;Ejhaem. 2022 Nov 1
- Join now to see all
Abstracts/Posters
- Overview of Primary and Secondary Myelofibrosis in Young Adults: Genomic Characteristics, Treatment Strategies and OutcomesChetasi Talati, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Clearance of Somatic Gene Mutations in Patients with Acute Myeloid Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation (HCT) Predicts OutcomeChetasi Talati, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- SF3B1 Clone Size Is an Independent Determinant for Overall Survival and Response to Treatment in Patients with Myelodysplastic SyndromeChetasi Talati, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Comparison of Overall Responses after Standard Induction with High Dose Daunorubicin Versus Standard Dose Daunorubicin with Gemtuzumab Ozogamicin in Favorable Risk Acu...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Increased Frequency of IDH1/2 Mutations in Extramedullary Acute Myeloid Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Clonal Suppression of TP53 Mutant MDS and Oligoblastic AML with Hypomethylating Agent Therapy Improves Overall Survival2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Industry Relationships
- Medical Director, AbbvieClinical Development- Multiple Myeloma2021 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
